EU regulatory framework for research peptides

Research peptide reagents sit inside a defined chemicals-and-customs framework rather than the medicines regime. Understanding how the EU and Moldova treat in-vitro research materials helps qualified laboratories source, document, and receive shipments correctly. This is informational background, not legal advice.

REACH and the scientific research exemption

In the EU, the registration, evaluation, authorisation and restriction of chemicals is governed by Regulation (EC) No 1907/2006 (REACH). REACH normally requires registration of substances manufactured or imported at one tonne or more per year, but it builds in proportionate relief for science. Substances used in scientific research and development, and in product and process oriented research and development, benefit from specific provisions, and Annex V lists categories exempted from the registration obligation. Most research peptides move in milligram-to-gram quantities, far below the tonnage trigger, so registration is typically not engaged. Exemption from registration does not remove duties of safe handling, accurate labelling, and lawful end use. The framing matters: a research reagent is a chemical substance characterised for laboratory work, not a medicinal product placed on the market for human use. Laboratories should keep the substance identity, intended scientific purpose, and quantities documented so the research context is demonstrable. Because thresholds and category scope are technical, verifying current REACH and ECHA guidance for a specific substance is prudent.

In-vitro and RUO labelling

Research Use Only (RUO) and for in-vitro research use are labelling conventions that define how a material may lawfully be supplied and applied. An RUO label states that the reagent is intended for laboratory research and is not for diagnostic, therapeutic, human, or animal use. This is a substantive boundary, not a disclaimer of convenience: a compound labelled and sold as a research reagent is positioned outside the medicines and the in-vitro diagnostic medical device frameworks, both of which carry their own EU regulations and conformity requirements. Correct labelling typically pairs the RUO statement with the compound name, a CAS number where one exists, batch or lot identification, net quantity, and storage conditions, supported by a Certificate of Analysis and a safety data sheet. For qualified researchers, the label and accompanying documentation establish what the material is and the only context in which it should be used. Misusing an RUO-labelled reagent outside laboratory research, or re-labelling it for any human or clinical application, falls outside this framework entirely and is not a use Peptiko supports.

End-use declarations and importer responsibilities

When research chemicals cross borders, the recipient is frequently the party best placed to attest to their purpose. An end-use declaration is a written statement from the receiving laboratory or institution confirming that the material is for in-vitro scientific research and not for human use, resale into clinical channels, or any prohibited application. Such declarations support the supplier's records, satisfy carrier and customs expectations, and reinforce the RUO chain of custody from manufacture to bench. Within the EU, importers and downstream users also have obligations under REACH, including reasonable due diligence on substance identity and safe handling, and the recipient acting as importer of record assumes the corresponding customs and compliance duties. For shipments into Moldova, the same logic applies: a clear statement of research end use, paired with accurate product and value documentation, helps customs classify the consignment correctly. Honest, consistent declarations are also a practical risk control, since vague or contradictory paperwork is a common trigger for inspection, delay, or refusal at the border.

HS codes and customs documentation

Every cross-border consignment needs a customs classification under the Harmonised System (HS), the international tariff nomenclature that determines duties, controls, and the documents required. Peptide research reagents are commonly considered under chapter 29 headings for organic chemicals such as 2933 or 2937 where the structure fits, or under heading 3822 for laboratory reagents and prepared diagnostic or laboratory preparations, depending on presentation and intended use. The correct code is a technical determination that should follow the actual nature of the goods rather than convenience, and a customs broker or the competent authority can confirm it for a specific product. Beyond the code, a compliant shipment generally travels with a commercial invoice stating the true description and value, a packing list, the Certificate of Analysis, a safety data sheet, and any end-use or research declaration. Accurate, internally consistent paperwork that matches the physical goods speeds clearance and demonstrates good faith. Misdeclaring identity, value, or HS code to avoid scrutiny is both a compliance failure and a frequent cause of seizure, so transparency is the durable approach.

Related guides

How to verify a Janoshik COA How to choose a research peptide supplier Janoshik Analytical, explained